Rockefeller Capital Management
BBH icon

Rockefeller Capital Management’s VanEck Biotech ETF BBH Stock Holding History

Rockefeller Capital Management’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Hold
11,862
– – ﹤0.01% 1293
2026
Q1 		$2.23M Hold
11,862
– – ﹤0.01% 1260
2025
Q4 		$2.25M Buy
11,862
+1
+0% +$185 ﹤0.01% 1198
2025
Q3 		$1.97M Buy
11,861
+50
+0.4% +$8.15K ﹤0.01% 1171
2025
Q2 		$1.81M Buy
11,811
+294
+3% +$43.8K ﹤0.01% 1143
2025
Q1 		$1.81M Hold
11,517
– – ﹤0.01% 1075
2024
Q4 		$1.81M Hold
11,517
– – ﹤0.01% 1046
2024
Q3 		$2.04M Hold
11,517
– – 0.01% 985
2024
Q2 		$1.94M Hold
11,517
– – 0.01% 984
2024
Q1 		$1.92M Buy
11,517
+25
+0.2% +$4.14K 0.01% 1021
2023
Q4 		$1.9M Hold
11,492
– – 0.01% 933
2023
Q3 		$1.79M Sell
11,492
-298
-3% -$47.6K 0.01% 885
2023
Q2 		$1.84M Buy
11,790
+298
+3% +$47.6K 0.01% 876
2023
Q1 		$1.86M Sell
11,492
-230
-2% -$37.2K 0.01% 839
2022
Q4 		$1.87M Buy
11,722
+230
+2% +$36.4K 0.01% 771
2022
Q3 		$1.62M Buy
11,492
+100
+0.9% +$15.1K 0.01% 835
2022
Q2 		$1.66M Hold
11,392
– – 0.01% 825
2022
Q1 		$1.85M Hold
11,392
– – 0.01% 824
2021
Q4 		$2.16M Hold
11,392
– – 0.01% 769
2021
Q3 		$2.3M Hold
11,392
– – 0.01% 718
2021
Q2 		$2.3M Hold
11,392
– – 0.01% 686
2021
Q1 		$2M Hold
11,392
– – 0.01% 577
2020
Q4 		$1.93M Hold
11,392
– – 0.01% 525
2020
Q3 		$1.85M Hold
11,392
– – 0.02% 451
2020
Q2 		$1.86M Hold
11,392
– – 0.02% 409
2020
Q1 		$1.46M Buy
11,392
+42
+0.4% +$5.66K 0.02% 399
2019
Q4 		$1.58M Buy
11,350
+10
+0.1% +$1.31K 0.02% 384
2019
Q3 		$1.34M Hold
11,340
– – 0.02% 345
2019
Q2 		$1.46M Hold
11,340
– – 0.02% 293
2019
Q1 		$1.46M Hold
11,340
– – 0.02% 310
2018
Q4 		$1.26M Buy
+11,340
New +$1.37M 0.02% 221

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rockefeller Capital Management's BBH Position: Q2 2026 in Review

Rockefeller Capital Management held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 11,862 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1293.

Rockefeller Capital Management first reported a position in BBH in Q4 2018 and has held it in 31 quarters since. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

  • Rockefeller Capital Management held 11,862 shares of VanEck Biotech ETF worth $2.41M as of Q2 2026.
  • Rockefeller Capital Management left its VanEck Biotech ETF share count unchanged in Q2 2026.
  • VanEck Biotech ETF made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1293 holding.
  • Rockefeller Capital Management first reported a position in VanEck Biotech ETF in Q4 2018 and has held it in 31 quarters since.
  • 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.